openPR Logo
Press release

Atrial Flutter Market Progresses For Huge Profits During 2025

03-09-2018 11:35 AM CET | Health & Medicine

Press release from: Transparency Market Research

Atrial Flutter Market Progresses For Huge Profits During 2025

Atrial flutter is abnormal heart rhythm. It is characterized by atrial rates of 240 to 400 beats per minute and blockage in atrioventricular node. Atrioventricular node controls the heart rate and is one of the major elements in the cardiac conduction system. Atrial flutter leads to irregular electrical impulse of the heart resulting in disorganized contraction in parts of heart and disability to pump required amount of blood. The common causes of atrial flutter include excessive alcohol consumption, coronary heart disease, heart bypass surgery, hypertension, heart valve disease, overactive thyroid gland, and sick sinus syndrome.

Rise in number of people with common diseases such as diabetes and obesity is expected to drive the global Atrial Flutter Market during the forecast period. Increase in prevalence of heart diseases such as congestive heart failure, heart attack, and stroke are also likely to propel the market. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally. More people die annually from cardiovascular diseases than from any other cause. Cardiovascular diseases accounted for an estimated 17.7 million deaths in 2015, representing 31% of all global deaths. Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million due to stroke.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39377

The global atrial flutter market can be segmented based on type of atrial flutter, treatment type, end-user, and region. In terms of type of atrial flutter, the market can be categorized into typical atrial flutter, reverse typical atrial flutter, incisional atrial re-entry, left atrial flutter, and atypical atrial flutter. Based on treatment type, the global atrial flutter market can be classified into catheter ablation treatment, acute treatment, anticoagulant treatment, surgical treatment, and others. Based on end-user, the market can be divided into hospitals, electrophysiology labs, ambulatory surgical centers, and others.

In terms of region, the global atrial flutter market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2016, owing to increase in prevalence of heart diseases. According to the Centers for Disease Control and Prevention, heart disease accounts for about 610,000 deaths in the U.S. each year i.e., 1 in every 4 deaths. Coronary heart disease (CHD) is the most common type of heart disease, accounting for over 370,000 deaths annually. Europe is expected to be the second largest market in terms of revenue. The market in the region is likely to be driven by increase in adoption of technologically advanced products, advanced health care facilities and infrastructure, and rise in prevalence of hypertension and obesity.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=39377

Asia Pacific is anticipated to register high growth from 2017 to 2025 due to factors such as increase in disposable income and aging patient population. According to the United Nations ESCAP, Asia Pacific is home to about 60% of the world’s geriatric population, defined as people at 60 years and older. The geriatric population is expected to more than double from 547 million in 2016 to nearly 1.3 billion by 2050. Countries such as Brazil and Mexico are expected to contribute to the growth of the market in Latin America due to improving medical infrastructure.

Key players operating in the global atrial flutter market include Boehringer Ingelheim GmbH, Johnson & Johnson Services, Inc., Abbott, Bristol-Myers Squibb Company, and Medtronic.

View Report -

https://www.transparencymarketresearch.com/atrial-flutter-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atrial Flutter Market Progresses For Huge Profits During 2025 here

News-ID: 971921 • Views: 257

More Releases from Transparency Market Research

Market Intelligence Report on Calcite Market, 2018-2028
Sales of calcite have witnessed utter proliferation in recent time, in line with the growing demand from paper and pulp sector wherein calcite is highly adopted as a coating and filler material. According to Transparency Market Research analysis, global calcite market is anticipated to register 4.7% CAGR during the study period 2018–2028. The TMR report opines that demand for calcite is highly driven by its significant properties that are paving way
Pearlescent Pigments Market Intelligence Report Offers Growth Prospects
The demand within the global pearlescent pigment market is slated to rise as new creative avenues emerge in the art and craft industry. Several artists have increased the consumption of pearlescent pigments, mainly due to the aesthetic value of these pigments in art forms. The use of these pigments can majorly be attributed to the gloss and shine imparted by these pigments to the design or craft. These pigments exhibit
Aragonite Market to Witness Steady Growth During the Forecast Period 2018-2026
Global Aragonite Market: Overview Aragonite is a carbonate mineral having an orthorhombic crystal system, and very closely resembles calcite. It is considered as the purest form of calcium carbonate. The mineral has garnered wide popularity as gemstone in various parts of the world and has promising healing properties with energy enhancing powers. Aragonite contains traces of magnesium and sand inclusion but rich in calcium carbonate, and is alkaline in nature. It
OEM Insulation Market Growth, Trends and Value Chain 2019-2027 by TMR
OEM Insulation Market – Overview OEM means Original Equipment Manufacturer that indicates to a company that produces a part or a subsystem of a product that is being used by another organization. Thermal insulation or simply insulation allows the product to cut down the heat gain or loss at the minimum by creating a barrier between the surfaces at the varying temperatures. There are wide range of applications and end-use verticals

All 5 Releases


More Releases for Atrial

Atrial Fibrillation Device Market Latest Trends and Forecast Analysis - 2026
Atrial fibrillation is a type of arrhythmias refers to as an irregular heart rhythm of the upper chamber of the heart i.e. erratically change of normal sequence electrical impulses. Atrial fibrillation is treated with medications by slowing the heart rate to the rhythm control stage. Atrial fibrillation may lead to blood cloth, heart failure, strokes and other heart related problems. If atrial fibrillation disease remains untreated it will double the
Atrial Fibrillation Market
Atrial Fibrillation Market is predicted to grow at a double digit CAGR over the forecast period (2017 to 2023). Atrial fibrillation, also denoted as AF, is an irregular or fast heart rhythm. It raises the dangers of chest pain, heart strokes, congestive heart failure, or cardiac discomfort. The typical indications of AF are dizziness, confusion, fainting, or tiredness. Therapeutic advancements and the burgeoning aged populace also drive the industry. Supportive clinical
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Atrial Fibrillation Market Opportunity Analysis, 2018-2026
Atrial fibrillation, also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart. Most episodes of atrial fibrillation have no symptoms or fewer symptoms such as intermittent heart palpitations, lightheadedness, fainting, chest pain, and shortness of breath. Atrial fibrillation is linked with an elevated risk of heart failure, stroke, and dementia. The disease is a kind of supraventricular tachycardia. Risk factors associated
Atrial Septal Defect Market Future Opportunities2017 - 2025
Global Atrial Septal Defect Market: Outlook Atrial septal defect is one of the most common congenital cardiac diseases and usually affects women more than men. It is characterized by a hole or defect in the interatrial septum that separates the heart’s two upper chambers, i.e., atria. The opening in the septum usually closes when the baby is born, but in few cases if the opening does not close, the hole
Atrial Fibrillation - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Atrial Fibrillation - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atrial Fibrillation - Pipeline Review, H2 2017, provides an overview of the Atrial Fibrillation (Cardiovascular) pipeline landscape. Atrial fibrillation is an irregular and often rapid heart rate that commonly causes poor blood flow to the body.